In both trials study drug was liraglutide
States Offering Broad GLP-1 Coverage for Obesity A total of 14 states, including California, Michigan, and Pennsylvania, provide Medicaid coverage for the most common GLP-1s approved for both Type 2 diabetes and obesity
Medical weight loss consultation benefits Coverage for semaglutide and tirzepatide treatment Wegovy, Ozempic, Zepbound, and Mounjaro eligibility GLP-1 medication benefits Prior authorization requirements Prescription drug coverage Deductibles, copays, and coinsurance Telehealth eligibility Medicare Advantage benefit review Alternative self-pay treatment options Insurance Coverage for Wegovy, Zepbound, Ozempic & Mounjaro Many commercial insurance plans now offer coverage for GLP-1 medications prescribed for eligible patients with obesity or weight-related medical conditions
Full reimbursement is likely to be unaffordable for most publicly funded healthcare systems in the short term, but a steady reduction in the threshold for reimbursement is believed to be inevitable in the medium to long term
Formally known as GLP-1 agonists, GLP-1s are a class of medication primarily used to manage Type 2 diabetes
If labs are required, its usually just once at the beginning